← All authors Marisa Miraldo Institute for Health Economics and Policy (per OpenAlex) · ORCID · OpenAlex
30 papers in scope · 29 published · 1 on the econ.EM arXiv · 804 citations · h-index 18 (over the papers listed here)
Papers (1 of 30)
Attribution of credit in acknowledgements: The case of systematic reviews in medicine
published 2026 · PLoS ONE · 1 citations
with Rossella Salandra, Paola Criscuolo
Innovation Diffusion Among Coworkers: Evidence from Senior Doctors
published 2025 · Management Science · 4 citations
The role of patient organisations in research and development: Evidence from rare diseases
published 2023 · Social Science & Medicine · 24 citations
with Arianna Gentilini
The impact of hospital price and quality transparency tools on healthcare spending: a systematic review
published 2022 · Health Economics Review · 31 citations
with Jinyang Chen
The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
published 2022 · Pharmaceutical Medicine · 16 citations
with Céline Aerts, Eliana Barrenho, Elisa Sicuri
Inequities in cancer drug development in terms of unmet medical need
published 2022 · Social Science & Medicine · 7 citations
with Eliana Barrenho, Réka Halmai, Iván Tzintzun, Setti Raïs Ali, Léa Toulemon, Jean-Claude K. Dupont, Lise Rochaix
working paper 2021 · arXiv · first circulated 2020
Is the road to good health paved in gold? HIV and mining in Sub-Saharan Africa
published 2020 · European Journal of Public Health
with C. Hansen, Katharina Hauck, Julius Ohrnberger
Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis
published 2019 · The Lancet Global Health · 32 citations
with Bryony Simmons, Graham Cooke
Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data
published 2019 · Journal of Health Economics · 27 citations
with Giovanni Crea, Matteo M. Galizzi, Ismo Linnosmaa
Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries
published 2018 · Health Economics · 47 citations
with Eliana Barrenho, Peter Smith
Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England
published 2018 · Health Economics · 30 citations
with Krystal Lau, Katharina Hauck
Waiting time at health facilities and social class: Evidence from the Indian caste system
published 2018 · PLoS ONE · 38 citations
with Mujaheed Shaikh, Anna-Theresa Renner
The impact of publicly subsidised health insurance on access, behavioural risk factors and disease management
published 2018 · Social Science & Medicine · 36 citations
Cost-Effectiveness and Dynamic Efficiency: Does the Solution Lie Within?
published 2017 · Value in Health · 14 citations
with Rodrigo Refoios Camejo, Frans Rutten
Are You What You Eat? Healthy Behaviour and Risk Preferences
published 2017 · The B E Journal of Economic Analysis & Policy · 21 citations
with Matteo M. Galizzi
Doctor–patient differences in risk and time preferences: A field experiment
published 2016 · Journal of Health Economics · 40 citations
with Matteo M. Galizzi, Charitini Stavropoulou, Marjon van der Pol
In Sickness but Not in Wealth
published 2016 · Medical Decision Making · 41 citations
with Matteo M. Galizzi, Charitini Stavropoulou
Health-care improvements in a financially constrained environment
published 2016 · The Lancet · 24 citations
with Inger Ekman, Reinhard Busse, Ewout van Ginneken, Chris Van Hoof, Linde van Ittersum, Ab Klink, Jan A.M. Kremer, Anders Olauson, W. De Raedt, Michal Rosen-Zvi, Valentina Strammiello, Jan Törnell, …
Socio-Psychological Factors Driving Adult Vaccination: A Qualitative Study (vol 9, e113503, 2014)
published 2014 · PLoS ONE · 70 citations
with Ana Wheelock, Anam Parand, B Rigole, Angus Thomson, Charles Vincent, Nick Sevdalis, Charlene D. Vincent
Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD
published 2013 · The European Journal of Health Economics · 8 citations
with Rodrigo Refoios Camejo, Clare McGrath, Frans Rutten
The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies
published 2013 · PharmacoEconomics · 6 citations
with Rodrigo Refoios Camejo, Clare McGrath, Frans Rutten
Price adjustment in the hospital sector. Reply
published 2011 · Journal of Health Economics
with Luigi Siciliani, Andrew Street
The effects of hospitals’ governance on optimal contracts: Bargaining vs. contracting
published 2010 · Journal of Health Economics · 14 citations
with Matteo M. Galizzi
Effects of Reference Pricing in Pharmaceutical Markets
published 2010 · PharmacoEconomics · 86 citations
with Matteo M. Galizzi, Simone Ghislandi
Price adjustment in the hospital sector
published 2010 · Journal of Health Economics · 21 citations · first circulated 2008
with Luigi Siciliani, Andrew Street
Are English treatment centres treating less complex patients?
published 2009 · Health Policy · 49 citations
with Andrew Street, Peter Sivey, Anne Mason, Luigi Siciliani
Should prospective payments be differentiated for public and private healthcare providers?
published 2009 · Health Economics Policy and Law · 18 citations
with Anne Mason, Andrew Street, Luigi Siciliani
Reference pricing and firms’ pricing strategies
published 2008 · Journal of Health Economics · 65 citations
Giving greater financial independence to hospitals—does it make a difference? The case of English NHS Trusts
published 2007 · Health Economics · 34 citations
with Giorgia Marini, Rowena Jacobs, Maria Goddard
Assembled from arXiv and OpenAlex. Duplicate records for the same paper are merged, and the published version is shown where we could identify one. Corrections welcome.
Built from arXiv and OpenAlex. Supported by UKRI grant APP47921 (Martin Weidner, UCL · Francis J. DiTraglia, Oxford).